Skip to Content
Merck
CN

HNS2MAG-95K

MILLIPLEX® Human Neuroscience Panel

Configurable Human Neuroscience 6-Plex Panel 2

Sign In to View Organizational & Contract Pricing.

About This Item

UNSPSC Code:
12161503
NACRES:
NA.47
eCl@ss:
32161000


Product Name

MILLIPLEX® Human Neuroscience Panel,

description

Configurable Human Neuroscience 6-Plex Panel 2

species reactivity

human

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

technique(s)

multiplexing: suitable

input

cerebrospinal fluid (CSF)
serum
plasma
cell culture supernatant(s)

assay range

accuracy: 124%
(Neurogranin), accuracy: 84%
(FABP3), accuracy: 85%
(ApoE4), accuracy: 94%
(TREM2), accuracy: 97%
(Angiogenin), sensitivity: 11.0 pg/mL
(MinDC + 2SD; TREM2), sensitivity: 14.3 pg/mL
(MinDC + 2SD; FABP3), sensitivity: 162.8 pg/mL
(MinDC + 2SD; ApoE4), sensitivity: 19.9 pg/mL
(MinDC + 2SD; Neurogranin), sensitivity: 5.8 pg/mL
(MinDC + 2SD; Angiogenin), sensitivity: 6.1 pg/mL
(MinDC + 2SD; Ferritin), standard curve range: 15-50,000 pg/mL
(TREM2), standard curve range: 2-10,000 pg/mL
(Angiogenin), standard curve range: 24-100,000 pg/mL
(FABP3), standard curve range: 244-1,000,000 pg/mL
(ApoE4), standard curve range: 5-20,000 pg/mL
(Neurogranin), standard curve range: 6-25,000 pg/mL
(Ferritin), inter-assay cv: <10%
intra-assay cv: <5%
(Angiogenin), inter-assay cv: <10%
intra-assay cv: <5%
(FABP3), inter-assay cv: <10%
intra-assay cv: <5%
(TREM2), inter-assay cv: <15%
intra-assay cv: <10%
(Ferritin), inter-assay cv: <15%
intra-assay cv: <10%
(Neurogranin), inter-assay cv: <15%
intra-assay cv: <5%
(ApoE4)

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

Neurogranin plays a pivotal role in learning and memory by modulating synaptic plasticity. TREM2, expressed on microglia, governs immune responses and facilitates amyloid clearance. ApoE4, a major genetic risk factor for Alzheimer′s, influences lipid metabolism and neuronal repair. FABP3 marks neuronal damage, while ferritin and angiogenin reflect neuroinflammatory activity and vascular health—together painting a multifaceted picture of brain dysfunction.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 6 analytes in human serum, plasma, and cerebrospinal fluid (CSF).

Analytes included: Angiogenin, Apolipoprotein E4 (ApoE4), Fatty Acid Binding Protein 3 (FABP3), Ferritin, Neurogranin, Triggering Receptor Expressed on Myeloid Cells 2 (TREM2).

Note: When testing serum/plasma samples, Angiogenin and ApoE4 require a 1:200 dilution while FABP3, Ferritin, Neurogranin and TREM2 require a 1:10 dilution. These sets of analytes should not be multiplexed together and instead run as separate assays. If testing CSF samples, all analytes can be plexed together.

Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

  • Comprehensive Pathway Coverage: Simultaneously quantify six critical neurological biomarkers spanning synaptic function, neuroinflammation, and lipid metabolism, providing a complete picture of neurodegeneration in a single assay.

  • Dual-Fluid Versatility: Analyze both challenging CSF samples and accessible blood samples with exceptional sensitivity, enabling flexible study designs while addressing the critical need for blood-based neurological biomarkers.

  • Research-Ready Reliability: Trust in consistent, reproducible results with < 5% intra-assay precision for most analytes and rigorous cross-reactivity testing, so your neuroscience discoveries are built on solid data foundations.

  • Streamlined Neuroscience Workflow: Eliminate the complexity of multiple single-analyte assays with our comprehensive 6-plex format, accelerating your research timeline and maximizing your sample utility for breakthrough neurological insights.

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.


Still not finding the right product?


pictograms

Skull and crossbonesEnvironment

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Sens. 1

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

Regulatory Information

新产品

This item has



Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library


Related Content

了解如何结合MILLIPLEX®多重和单分子计数(SMC®)高灵敏度蛋白免疫测定技术,检测人脑脊液、血浆和血清样本中的阿尔茨海默病(AD)生物标志物,开展神经科学深度研究。

Discover the benefits of MILLIPLEX® multiplex assays, based on Luminex® xMAP® multiplex assay technology, that provide consistent, high-quality results and see how these multiplex biomarker Luminex® assays are being used to advance research.

Neuroscience multiplex assays, such as MILLIPLEX® multiplex assays, enable simultaneous measurement of neuroscience-related biomarkers to gain a better picture of neurodegenerative diseases, neurological disorders, and neuropeptide/neurohormone signaling.

View All Related Content

Frederic Brosseron et al.
Journal of neurochemistry, 157(6), 2210-2224 (2020-09-08)
There is growing evidence that promising biomarkers of inflammation in Alzheimer´s disease (AD) and other neurodegenerative diseases correlate strongest to levels of tau or neurofilament, indicating an inflammatory response to neuronal damage or death. To test this hypothesis, we investigated